<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>20</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2021</Year>
        <Month>08</Month>
        <Day>07</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A Case of Shield Ulcer Due to Vernal Keratoconjunctivitis</title>
    <FirstPage>505</FirstPage>
    <LastPage>508</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Dilek</FirstName>
        <LastName>&#xD6;zkaya</LastName>
        <affiliation locale="en_US">Department of Ophthalmology, Faculty of Medicine, S&#xFC;leyman Demirel University, Isparta, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>G&#xFC;l&#x15F;ah</FirstName>
        <LastName>Usta</LastName>
        <affiliation locale="en_US">Department of Ophthalmology, Faculty of Medicine, S&#xFC;leyman Demirel University, Isparta, Turkey</affiliation>
      </Author>
      <Author>
        <FirstName>Umut</FirstName>
        <LastName>Karaca</LastName>
        <affiliation locale="en_US">Department of Ophthalmology, Faculty of Medicine, S&#xFC;leyman Demirel University, Isparta, Turkey</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>06</Month>
        <Day>30</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2020</Year>
        <Month>12</Month>
        <Day>26</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Corneal shield ulcer is an uncommon but serious complication of vernal keratoconjunctivitis (VKC) that can threaten visual acuity. We present a 12-year-old case with a corneal shield ulcer on the superior part of the cornea in the right eye. We learned from his history that he was treated with topical cyclosporine A (CsA) and corneal debridement was performed for the same complaints six months ago. His complaints recurred six months after ceasing topical CsA voluntarily. Topical anti-allergic and CsA treatments were commenced, we also performed corneal debridement. During his follow-ups, the corneal ulcer healed leaving a scar as opacity and neovascularization. This case highlights the role of the anti-inflammatory effect of CsA in preventing the recurrence of shield ulcers.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/2877</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/2877/1685</pdf_url>
  </Article>
</Articles>
